258 related articles for article (PubMed ID: 7060530)
1. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
Garcia M; Greene G; Rochefort H; Jensen EV
Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
Keene JL; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
4. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
6. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical and genetic evidence for specific antiestrogen binding sites.
Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
[TBL] [Abstract][Full Text] [Related]
8. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
Toko T; Shibata J; Nukatsuka M; Yamada Y
Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952
[TBL] [Abstract][Full Text] [Related]
10. Evidence for 5 alpha-androstane-3 beta, 17 beta-diol binding to the estrogen receptor in the cytosol from male rat pituitary.
Thieulant ML; Samperez S; Jouan P
Endocrinology; 1981 Apr; 108(4):1552-60. PubMed ID: 7472283
[TBL] [Abstract][Full Text] [Related]
11. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies.
Giambiagi N; Pasqualini JR
J Steroid Biochem; 1988; 30(1-6):213-7. PubMed ID: 3386244
[TBL] [Abstract][Full Text] [Related]
12. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
Faye JC; Fargin A; Bayard F
Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
[TBL] [Abstract][Full Text] [Related]
13. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
Borgna JL; Rochefort H
Mol Cell Endocrinol; 1980 Oct; 20(1):71-85. PubMed ID: 7439523
[TBL] [Abstract][Full Text] [Related]
14. Different interaction of estradiol and antiestrogens with the estrogen receptor of rat uterus.
Faye JC; Fargin A; Bayard F
Mol Cell Endocrinol; 1986 Sep; 47(1-2):119-24. PubMed ID: 3743888
[TBL] [Abstract][Full Text] [Related]
15. The two native estrogen receptor forms of 8S and 4S present in cytosol from human uterine tissues display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element.
Navarro D; León L; Chirino R; Fernández L; Pestano J; Díaz-Chico BN
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):49-58. PubMed ID: 9569010
[TBL] [Abstract][Full Text] [Related]
16. Site-specific antibodies to the DNA-binding domain of estrogen receptor distinguish this protein from the 3H-estradiol-binding protein in pancreas.
Grossman A; Traish A
Life Sci; 1992; 51(11):859-67. PubMed ID: 1381803
[TBL] [Abstract][Full Text] [Related]
17. Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: evidence for an endogenous ligand.
Murphy PR; Butts C; Lazier CB
Endocrinology; 1984 Jul; 115(1):420-6. PubMed ID: 6734522
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
19. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
Hutchens TW; McNaught RW; Yip TT; Suzuki T; Li CM; Besch PK
Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
[TBL] [Abstract][Full Text] [Related]
20. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
